Evidence map›Paper›PMID 42526433›Full record

ArticleCurrent biology : CB2026

Evolution of a core ribosomal innovation in octopus.

Rishav Mitra, Richard Han, Trey J Scott, Anik G Grearson, Jessica A Willi, Christina G Liu, Hyeongju Kim, Michael C Jewett, Nicholas W Bellono, Amy S Y Lee

Abstract read
In one paragraph

Article in Current biology : CB, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Rishav MitraDepartment of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Richard HanDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Trey J ScottDepartment of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA; Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA; Museum of Comparative Zoology, Harvard University, Cambridge, MA 02138, USA.
Anik G GrearsonDepartment of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Jessica A WilliDepartment of Biochemistry, University of Lethbridge, Lethbridge, AB T1K 3M4, Canada; Chemical and Biological Engineering, Northwestern University, Tech E-135, 2145 Sheridan Road, Evanston, IL 60208, USA.
Christina G LiuDepartment of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Hyeongju KimDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Michael C JewettChemical and Biological Engineering, Northwestern University, Tech E-135, 2145 Sheridan Road, Evanston, IL 60208, USA.
Nicholas W BellonoDepartment of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA. Electronic address: nbellono@harvard.edu.
Amy S Y LeeDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: amysy_lee@dfci.harvard.edu.

Funding

Molecular Mechanisms of Integrative Signal TransductionR35GM142697 · NIGMS · HARVARD UNIVERSITY · PI Nicholas Bellono · 2021 to 2026
$2.6M
Notice of Special Interest - R35 (Undergraduate Summer Funding)R35GM142527 · NIGMS · DANA-FARBER CANCER INST · PI LEE, AMY SI-YING · 2021 to 2025
$2.2M
Biological Novelty through Adaptive Protein Synthesis in the OctopusF31NS132412 · NINDS · HARVARD MEDICAL SCHOOL · PI HAN, RICHARD · 2024 to 2024
$35k
NIGMS NIH HHS R35 GM142527NIGMS NIH HHS R35 GM142697NINDS NIH HHS F31 NS132412
6 · The paper itself

Abstract

Much of biology focuses on how genetic changes mediate new functions, but less attention is given to adaptations within the ancient molecular machines that execute the central dogma. Octopuses exhibit complex nervous systems and sophisticated behaviors that rival vertebrates but via an entirely divergent evolutionary history. Here, we serendipitously discovered that octopus ribosomes contain a structural break in the core ribosomal RNA that is unique among all animals. This break site enhances translation fidelity to reduce miscoding and subsequent protein aggregation, even when engineered into evolutionarily distant bacterial ribosomes. Furthermore, high-fidelity translation by octopus ribosomes supports proteomic stability during extensive RNA editing observed in cephalopods, suggesting synergy between distinct non-canonical modes of gene regulation. This adaptation emerged in recently derived octopuses with expanded nervous systems, thereby revealing a mechanism that could broadly support the evolution of novel organismal traits.

Indexed as

Evolution, MolecularOctopodiformesRibosomesRNA, RibosomalAnimalsProtein BiosynthesisRNA EditingRNA, Ribosomal28S rRNAcephalopodoctopusprotein aggregationproteostasisribosomeribosome evolutionRNA editingrRNA breaktranslation fidelity

Identifiers

PMID42526433
PMCPMC13426061

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.